|Articles|October 15, 2002
- BioPharm International-10-01-2002
- Volume 15
- Issue 10
Preparing Biological Product Deviation Reports: Suggestions for Manufacturers
Author(s)Barbara Unger
by Barbara W. Unger, Don Hill Associates, Inc. Rarely do manufacturers of biologics need to prepare a Biological Product Deviation Report (formerly called and Error and Accident Report); in fact, few manufacturers ever have to complete one. But all manufacturers need to have an SOP describing how to complete this report, in case it becomes necessary.
Advertisement
Articles in this issue
about 23 years ago
FDA Launches Major CGMP Reviewabout 23 years ago
Process Validation: How Much to Do and When to Do Itabout 23 years ago
Biotech Will Recover!about 23 years ago
GMPs and Pharmaceutical Labelingabout 23 years ago
Revolutionizing Biologics RegulationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement